Market cap
$107,395 Mln
Revenue (TTM)
$48,919 Mln
P/E Ratio
23.7
P/B Ratio
1.3
Div. Yield
9.2 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 9.39 | 14.58 | 13.42 | 1.97 | 5.43 |
| EBIT | -48.46 | -25.61 | 11.11 | -8.44 | 2.83 |
| Net Profit | -80.78 | -92.15 | -56.90 | -22.93 | -9.22 |
| EPS | -78.61 | -91.02 | -55.93 | -22.19 | -6.85 |
| Book Value | -- | -- | -5.41 | -0.65 | 3.05 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 16.03 | 18.93 | 18.18 | 14.56 | 16.82 |
| Net Margin
| -- | -- | 8.09 | -- | -- |
| Return on equity
| 8.36 | 9.24 | 5.56 | 10.50 | 7.34 |
| Return on Capital
| 6.66 | 7.19 | -- | 8.35 | 5.91 |
| Return on Assets
| 4.86 | 5.33 | 2.51 | 6.02 | 4.29 |
| Debt to Equity (x)
| -- | -- | 0.21 | 0.28 | 0.23 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
--
|
8.35
|
5.91
|
5.72
|
8.95
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
5.56
Lower than Peers by 13.42
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
5.56
|
10.50
|
7.34
|
7.26
|
11.67
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
ROA
2.51
Lower than Peers by 0.34
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
2.51
|
6.02
|
4.29
|
4.27
|
6.78
|
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
EBIT Margin
18.18
Higher than Peers by 2.36
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
18.18
|
14.56
|
16.82
|
16.73
|
25.65
|
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
Net Margin
8.09
Lower than Peers by 0.14
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
8.09
|
16.72
|
12.55
|
12.98
|
20.64
|
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
13.42
Higher than Peers by 5.37
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
13.42
|
0.05
|
0.06
|
0.03
|
0.04
|
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
EBIT Growth
11.11
Higher than Peers by 2.84
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
11.11
|
-8.67
|
6.98
|
-33.08
|
27.06
|
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
Net Profit Growth
-56.90
Lower than Peers by 64.63
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
-56.90
|
40.52
|
2.96
|
-35.49
|
34.52
|
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
EPS Growth
-55.93
Lower than Peers by 66.32
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
-55.93
|
0.44
|
0.03
|
-0.35
|
0.35
|
|
Peer Median
|
10.39
|
--
|
--
|
--
|
--
|
Book Value Growth
1.94
Lower than Peers by 2.94
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
1.94
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.87
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.21
Lower than Peers by 0.38
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
0.21
|
0.28
|
0.23
|
0.25
|
0.28
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.10
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
0.10
|
0.06
|
0.06
|
0.04
|
0.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.99
Lower than Peers by 0.66
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
0.99
|
1.09
|
1.46
|
1.27
|
1.42
|
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
Quick Ratio
0.23
Lower than Peers by 0.97
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
0.23
|
0.73
|
1.14
|
0.87
|
1.05
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
9.78
Higher than Peers by 5.01
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
9.78
|
10.86
|
11.96
|
13.57
|
27.03
|
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
18.82
Lower than Peers by 2.45
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
18.82
|
23.65
|
24.00
|
26.53
|
26.49
|
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
Asset Turnover
0.31
Lower than Peers by 0.09
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
0.31
|
0.36
|
0.34
|
0.33
|
0.33
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
--
|
84.73
|
89.36
|
95.60
|
92.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
--
|
274.94
|
264.11
|
269.37
|
271.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
--
|
208.70
|
205.78
|
204.51
|
199.70
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Sanofi ADS - ADR
|
--
|
150.97
|
147.69
|
160.46
|
164.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|